Report Overview
The global Renin-Angiotensin-System (RAS)-Acting Agent market was valued at million in 2024 and is projected to reach US$ million by 2031, at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Prospect Research Reports (PRR) has surveyed the Renin-Angiotensin-System (RAS)-Acting Agent manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Renin-Angiotensin-System (RAS)-Acting Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renin-Angiotensin-System (RAS)-Acting Agent. This report contains market size and forecasts of Renin-Angiotensin-System (RAS)-Acting Agent in global, including the following market information:
Global Renin-Angiotensin-System (RAS)-Acting Agent market revenue, 2020-2025, 2026-2031, ($ millions)
Global Renin-Angiotensin-System (RAS)-Acting Agent market sales, 2020-2025, 2026-2031, (K Units)
Global top five Renin-Angiotensin-System (RAS)-Acting Agent companies in 2024 (%)
Total Market by Segment:
Global Renin-Angiotensin-System (RAS)-Acting Agent market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent market segment percentages, by Type, 2024 (%)
Angiotensin Converting Enzyme Inhibitors (ACEi)
Angiotensin Receptor Blockers (ARBs)
Global Renin-Angiotensin-System (RAS)-Acting Agent market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent market segment percentages, by Application, 2024 (%)
Hypertension
Heart Failure
Chronic Kidney Disease
Other
Global Renin-Angiotensin-System (RAS)-Acting Agent market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Renin-Angiotensin-System (RAS)-Acting Agent market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renin-Angiotensin-System (RAS)-Acting Agent revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Renin-Angiotensin-System (RAS)-Acting Agent revenues share in global market, 2024 (%)
Key companies Renin-Angiotensin-System (RAS)-Acting Agent sales in global market, 2020-2025 (estimated), (K Units)
Key companies Renin-Angiotensin-System (RAS)-Acting Agent sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Sanofi S.A.
Bristol-Myers Squibb Company
Daiichi Sankyo Company,Limited
Takeda Pharmaceutical Company Limited
Boehringer lngelheim GmbH
Johnson & Johnson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Renin-Angiotensin-System (RAS)-Acting Agent, market overview.
Chapter 2: Global Renin-Angiotensin-System (RAS)-Acting Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Renin-Angiotensin-System (RAS)-Acting Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Renin-Angiotensin-System (RAS)-Acting Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Renin-Angiotensin-System (RAS)-Acting Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
